Literature DB >> 22085047

Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes.

Malin K B Jonsson1, Qing-Dong Wang, Bruno Becker.   

Abstract

The xCELLigence real time cell analyzer Cardio system offers a new system for real-time cell analysis that measures impedance-based signals in a label-free noninvasive manner. The aim of this study was to test whether impedance readings are a useful tool to detect compound effects on beating frequency (beats per minute, bpm) and arrhythmias of human induced pluripotent stem cell- and a mouse embryonic stem cell-derived cardiomyocyte line (hiPSC-CM and mESC-CM, respectively). Baseline values for control wells were 45±3 and 179±6 bpm, respectively (n=6). Correspondingly, isoproterenol increased beating frequency by 77% and 71%, whereas carbachol decreased frequency by 11% and 100% (stopped in 5/6 mESC-CM wells). E-4031 decreased beating rate and caused arrhythmias in both cell types, however, more pronounced in the human iPSC-CMs. Amlodipine inhibited contractions in both models, and T-type calcium channel block strongly reduced beating rate and eventually stopped beating in mESC-CM but caused a smaller effect in hiPSC-CM. The results of this initial study show that, under the right conditions, the beating frequency of a monolayer of cells can be stably recorded over several days. Additionally, the system detects changes in beating frequency and amplitude caused by added reference compounds. This assay system has the potential to enable medium-throughput screening, but for implementation into routine daily work, extended validation, testing of additional batches of cardiomyocytes, and further assay optimization (e.g., frequency of media exchange, growth matrix, seeding density, age of cells after plating, and temperature control) will be needed. © MARY ANN LIEBERT, INC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085047      PMCID: PMC3232633          DOI: 10.1089/adt.2011.0396

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  33 in total

1.  Intracellular Ca2+ oscillations drive spontaneous contractions in cardiomyocytes during early development.

Authors:  S Viatchenko-Karpinski; B K Fleischmann; Q Liu; H Sauer; O Gryshchenko; G J Ji; J Hescheler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs.

Authors:  Tomomi G Otsuji; Itsunari Minami; Yuko Kurose; Kaori Yamauchi; Masako Tada; Norio Nakatsuji
Journal:  Stem Cell Res       Date:  2010-02-06       Impact factor: 2.020

3.  The xCELLigence system for real-time and label-free monitoring of cell viability.

Authors:  Ning Ke; Xiaobo Wang; Xiao Xu; Yama A Abassi
Journal:  Methods Mol Biol       Date:  2011

4.  Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes.

Authors:  Malin Kb Jonsson; Toon Ab van Veen; Marie-Jose Goumans; Marc A Vos; Göran Duker; Peter Sartipy
Journal:  Expert Opin Drug Discov       Date:  2009-04       Impact factor: 6.098

5.  Bradycardic and proarrhythmic properties of sinus node inhibitors.

Authors:  Juliane Stieber; Karen Wieland; Georg Stöckl; Andreas Ludwig; Franz Hofmann
Journal:  Mol Pharmacol       Date:  2005-12-30       Impact factor: 4.436

6.  Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker.

Authors:  S I Ertel; J P Clozel
Journal:  Expert Opin Investig Drugs       Date:  1997-05       Impact factor: 6.206

7.  Modelling the long QT syndrome with induced pluripotent stem cells.

Authors:  Ilanit Itzhaki; Leonid Maizels; Irit Huber; Limor Zwi-Dantsis; Oren Caspi; Aaron Winterstern; Oren Feldman; Amira Gepstein; Gil Arbel; Haim Hammerman; Monther Boulos; Lior Gepstein
Journal:  Nature       Date:  2011-01-16       Impact factor: 49.962

8.  Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity.

Authors:  Anne Royer; Sophie Demolombe; Aziza El Harchi; Khaï Le Quang; Julien Piron; Gilles Toumaniantz; David Mazurais; Chloé Bellocq; Gilles Lande; Cécile Terrenoire; Howard K Motoike; Jean-Christophe Chevallier; Gildas Loussouarn; Colleen E Clancy; Denis Escande; Flavien Charpentier
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

9.  Use-dependent block of the pacemaker current I(f) in rabbit sinoatrial node cells by zatebradine (UL-FS 49). On the mode of action of sinus node inhibitors.

Authors:  M Goethals; A Raes; P P van Bogaert
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

Review 10.  Amlodipine: a once daily calcium antagonist.

Authors:  R A Burges
Journal:  J Hum Hypertens       Date:  1991-08       Impact factor: 3.012

View more
  26 in total

1.  Functional Characterization of Human Stem Cell-Derived Cardiomyocytes.

Authors:  Glenn E Kirsch; Carlos A Obejero-Paz; Andrew Bruening-Wright
Journal:  Curr Protoc Pharmacol       Date:  2014

2.  Cross - site comparison of excitation-contraction coupling using impedance and field potential recordings in hiPSC cardiomyocytes.

Authors:  Corina T Bot; Krisztina Juhasz; Fabian Haeusermann; Liudmila Polonchuk; Martin Traebert; Sonja Stoelzle-Feix
Journal:  J Pharmacol Toxicol Methods       Date:  2018-06-22       Impact factor: 1.950

3.  Diffraction-based technology for the monitoring of contraction dynamics in 3D and 2D tissue models.

Authors:  Ronan Le Harzic; Ina Meiser; Julia C Neubauer; Iris Riemann; Michael Schiffer; Frank Stracke; Heiko Zimmermann
Journal:  Biomed Opt Express       Date:  2020-01-02       Impact factor: 3.732

Review 4.  Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Authors:  Yosuke K Kurokawa; Steven C George
Journal:  Adv Drug Deliv Rev       Date:  2015-07-23       Impact factor: 15.470

Review 5.  Concise review: drug discovery in the age of the induced pluripotent stem cell.

Authors:  Huaising C Ko; Bruce D Gelb
Journal:  Stem Cells Transl Med       Date:  2014-02-03       Impact factor: 6.940

6.  Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.

Authors:  Enrique G Navarrete; Ping Liang; Feng Lan; Verónica Sanchez-Freire; Chelsey Simmons; Tingyu Gong; Arun Sharma; Paul W Burridge; Bhagat Patlolla; Andrew S Lee; Haodi Wu; Ramin E Beygui; Sean M Wu; Robert C Robbins; Donald M Bers; Joseph C Wu
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

Review 7.  Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.

Authors:  Ian Y Chen; Elena Matsa; Joseph C Wu
Journal:  Nat Rev Cardiol       Date:  2016-03-24       Impact factor: 32.419

8.  Application of xCELLigence RTCA Biosensor Technology for Revealing the Profile and Window of Drug Responsiveness in Real Time.

Authors:  Dan Kho; Christa MacDonald; Rebecca Johnson; Charles P Unsworth; Simon J O'Carroll; Elyce du Mez; Catherine E Angel; E Scott Graham
Journal:  Biosensors (Basel)       Date:  2015-04-16

9.  Prospective in vitro models of channelopathies and cardiomyopathies.

Authors:  Nanako Kawaguchi; Emiko Hayama; Yoshiyuki Furutani; Toshio Nakanishi
Journal:  Stem Cells Int       Date:  2012-03-27       Impact factor: 5.443

10.  Label-free and dynamic monitoring of cytotoxicity to the blood-brain barrier cells treated with nanometre copper oxide.

Authors:  Duan Lian; Zhang Chonghua; Gu Wen; Zhang Hongwei; Bai Xuetao
Journal:  IET Nanobiotechnol       Date:  2017-12       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.